Publication | Open Access

Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels

Immunocell BakBrm-activated KillerMedicineMalignant Blood DisorderImmunologyCell DeathImmune Checkpoint InhibitorPrognostic SignificanceCancer TreatmentImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentCancer Research